Skip to content

CARL CARL Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction

Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction at other companies

3D Systems logo
3D SystemsDDD
$332K
OrthoPediatrics logo
OrthoPediatricsKIDS
$289K

Other financials

Income statement

See full
Revenue$16.1M+58.2%
Gross profit$12.4M+62.7%
Operating income-$9.3M-62.2%
Net income-$8.7M-51.8%
EPS (diluted)-$0.32+78.2%

Balance sheet

See full
Cash & equivalents$73.0M+68.1%
Total debt$17.3M
Total equity$92.2M+220%
Total assets$118.8M

Cash flow

See full
Operating cash flow-$13.0M-59.5%
CapEx$79.0K-4.8%
Free cash flow-$13.1M-58.8%

Valuation

See full
Market cap$305.56M-20.3%
Enterprise value$249.8M
P/S5.4×

Profitability

See full
Gross margin75.9%+1.4pp
Operating margin-60.5%-10.2pp
Net margin-57.8%-11.2pp
FCF margin-61.1%

Returns & leverage

See full
Return on equity-416.9%
Debt / equity0.2×
Current ratio11.9×

Where this comes from

Reported directly by CARL in its filing.

Tagged under the XBRL concept us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.

The official record: CARL’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about CARL's debt issuance costs incurred during noncash or partial noncash transaction.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CARL's debt issuance costs incurred during noncash or partial noncash transaction?
CARL (CARL) reported debt issuance costs incurred during noncash or partial noncash transaction of $0 in Q4 2025.
How has CARL's debt issuance costs incurred during noncash or partial noncash transaction changed year-over-year?
CARL's debt issuance costs incurred during noncash or partial noncash transaction decreased by 100.0% year-over-year, from $105.75K to $0.
What does debt issuance costs incurred during noncash or partial noncash transaction mean?
Quantifies the non-cash portion of costs associated with issuing debt, such as the value of equity instruments granted to lenders. This metric provides transparency into the total cost of financing beyond simple cash interest payments. It is critical for evaluating the true economic cost of debt-based capital raises.